Yu-Hsuan Fu

12PUBLICATIONS

43CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersGene and molecular therapyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jul 12, 2026

Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironment.

|Jun 22, 2026

Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia.

|Jun 04, 2026

Multiomic State-Transitions Reveal Post-Treatment Transcriptome Desynchronization in Acute Myeloid Leukemia.

|May 12, 2026

Targeting PRMT9 Overcomes Venetoclax Resistance in AML by Modulating Splicing and Inhibiting Translation.

|Apr 21, 2026

HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia.

|Feb 17, 2026

Modulating metabolic signatures to mitigate cabozantinib resistance in FLT3-ITD acute myeloid leukemia cell models.

Yu-Hsuan Fu, Kit Man Ng, Chi-Yang Tseng

Pageof 2

Frequent Collaborators

Ya-Huei Kuo

Liang-In Lin

Bin Zhang

Russell Rockne

Guido Marcucci

Da-Liang Ou

David E Frankhouser

Denis O'Meally

Stephen J Forman

Hsin-An Hou

Frequent Collaborators

Ya-Huei Kuo

Liang-In Lin

Bin Zhang

Russell Rockne